Genetic engineering company Colossal Biosciences said Tuesday that it will try to resurrect the extinct dodo bird, and it’s received $150 million in new funding to support its “de-extinction” activities.
The dodo was already part of Colossal’s plans by September 2022, but now the company has announced it with all the pomp, circumstance, and seed funding that suggests it will actually go after that goal. The $150 million, the company’s second round of funding, was led by several venture capital firms, including United States Innovative Technology Fund and In-Q-Tel, a VC firm funded by the CIA that first put money into the company in September.
Dodo bird
Adding the dodo to its official docket brings Colossal’s total de-extinction targets to three: the woolly mammoth (the company’s first target species, announced in September 2021), and the thylacine, a.k.a. the Tasmanian tiger, the largest carnivorous marsupial.
If they can do that with animals, I wonder if they could do the same with humans. I really would like to ask my great-great-grandfather some questions!